Clinical Trials Directory

Trials / Unknown

UnknownNCT01709565

Lactate Clearance According to the Presence of Hepatic Dysfunction

Lactate Clearance and Mortality in Patients With Severe Sepsis and Septic Shock: Comparison by Hepatic Dysfunction

Status
Unknown
Phase
Study type
Observational
Enrollment
245 (estimated)
Sponsor
Samsung Medical Center · Academic / Other
Sex
All
Age
20 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to compare lactate clearance in patients with severe sepsis and septic shock according to the presence of hepatic dysfunction.

Detailed description

Lactate clearance is well known to be associated with mortality in patients with severe sepsis and septic shock. To normalize lactate levels is one of important goals of early resuscitation of sepsis patients. Lactate clearance can be changed by various factors including patient characteristics, severity of shock, and treatment. In particular, hepatic dysfunction might impair the clearance of lactate because liver is a principal organ for lactate metabolism. However, an association between lactate clearance and hepatic failure has not been evaluated during initial resuscitation of patients with severe sepsis and septic shock. The primary goal of this study is to compare lactate clearance in patients with severe sepsis and septic shock according to the presence of hepatic dysfunction. The secondary goal is to evaluate if lactate clearance is associated with mortality even in patients with hepatic dysfunction.

Conditions

Timeline

Start date
2012-07-01
Primary completion
2014-06-01
Completion
2014-06-01
First posted
2012-10-18
Last updated
2012-10-18

Locations

1 site across 1 country: South Korea

Source: ClinicalTrials.gov record NCT01709565. Inclusion in this directory is not an endorsement.